MCRB
Seres Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$5.11-4.13%
Price as of Jul 20, 2026
MCRB valuation
Seres Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 70.49x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.87x
- Price / sales
- 43.14x
- Price / cash flow
- -1.17x
Enterprise value
- Enterprise value
- $100.1M
- EV / sales
- 87.31x
- EV / EBITDA
- -2.39x
- EV / EBIT
- -1.14x
- Market cap
- $49.5M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.